AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glycinova G 1mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Ikon Remedies Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glycinova G 1mg/500mg Tablet ER

Diabetic patients utilizing the extended-release Glycinova G 1mg/500mg tablet, an anti-diabetic medication, should understand its dual-medicine composition for type 2 diabetes management in adults. This formulation regulates blood glucose, requiring consistent daily intake at the same time, preferably with food. Dosage is individualized and adjusted based on blood sugar monitoring; discontinuation necessitates physician consultation as abrupt cessation elevates blood sugar risk, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Glycinova G is part of a comprehensive diabetes plan, incorporating diet, exercise, and weight management as directed. Hypoglycemia (low blood sugar), manifested by sweating, dizziness, headache, or trembling, is a frequent side effect. Maintaining regular meals and carrying readily-available glucose sources is crucial; alcohol consumption should be minimized. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, upper respiratory infections, and weight gain. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease, pregnant women, and breastfeeding mothers should seek medical advice before commencing treatment. Regular blood sugar checks, along with blood cell and liver function monitoring, are recommended.

Primary Ingredients of Glycinova G 1mg/500mg Tablet ER

The provided text is "undefined," so there is nothing to rephrase.

Uses of Glycinova G 1mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glycinova G 1mg/500mg Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; do not chew, crush, or fracture it. Glycinova G 1mg/500mg Extended-Release Tablets should be administered with a meal.

Common Side effects of Glycinova G 1mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glycinova G 1mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glycinova G 1mg/500mg Extended-Release Tablets. Ingest the tablet whole; do not crush, chew, or break it. Administer this medication with food.

How Glycinova G 1mg/500mg Tablet ER works:

Glycinova G 1mg/500mg Extended-Release tablets combine glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glycinova G 1mg/500mg Extended-Release Tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glycinova G tablets (1mg/500mg) may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glycinova G 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glycinova G 1mg/500mg Extended-Release tablets, potentially requiring dosage modification. Physician consultation is recommended. Glycinova G 1mg/500mg Extended-Release tablets are contraindicated in individuals with severe kidney disease. Close monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glycinova G 1mg/500mg Extended-Release tablets cautiously, potentially requiring dose modification. Physician consultation is advised. For those with mild to moderate hepatic dysfunction, a low initial dose is typically recommended; however, its use is contraindicated in patients with severe liver disease.

What if you forget to take Glycinova G 1mg/500mg Tablet ER :

Should you forget to take a Glycinova G 1mg/500mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glycinova G 1mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glycinova G 1mg/500mg Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glycinova G 1mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Glycinova G and seek immediate medical attention.
Glycinova G 1mg/500mg Extended-Release Tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glycinova G is not suitable for treating type 1 diabetes.
Glycinova G 1mg/500mg ER tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glycinova G 1mg/500mg Tablet ER use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glycinova G 1mg/500mg ER tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Consuming alcohol while taking Glycinova G 1mg/500mg Tablet ER is unsafe. Alcohol may exacerbate the drug's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glycinova G 1mg/500mg Tab...
33
MRP 40
18% off